Chemotherapy: advanced Hodgkin lymphoma - balancing toxicity and cure
Lim, Sean H. and Johnson, Peter W.M. (2011) Chemotherapy: advanced Hodgkin lymphoma - balancing toxicity and cure. Nature Reviews Clinical Oncology, 8, (11), 634-636. (doi:10.1038/nrclinonc.2011.137). (PMID:21894205).
Full text not available from this repository.
The combination of doxorubicin, bleomycin, vincristine and dacarbazine (ABVD) has emerged as a standard of care in advanced-stage Hodgkin lymphoma over the past four decades. Clinicians treating patients with cancer frequently walk a tightrope where the requirements of efficacy have to be balanced against the morbidity caused by the treatment.
|Subjects:||R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RM Therapeutics. Pharmacology
|Divisions:||Faculty of Medicine > Cancer Sciences
|Date Deposited:||04 Jul 2012 10:35|
|Last Modified:||26 Apr 2013 06:18|
|Contributors:||Lim, Sean H. (Author)
Johnson, Peter W.M. (Author)
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)